Tag: medicinal cannabis sector
Cann Group receives $3.2M R&D refund for cannabis med manufacture
Medicinal cannabis supplier and manufacturer Cann Group Limited (ASX:CAN) received today a research and development (R&D) tax incentive refund amounting to $3.2 million.
The Australian...
Cann Group inks broad R&D agreement with CSIRO
Listed medicinal cannabis company Cann Group has inked a broad, multiyear agreement with CSIRO that extends the research and development collaboration between the two parties.
The...
Featured Article
Good Design Australia opens entries for 2026 awards
For more than six decades, Good Design Australia has celebrated the power of design to shape innovation, industry, and everyday life. Its flagship program, the Australian Good Design Awards, recognises projects that show how thoughtful design can enhance products, services, systems, and communities.
